Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
6 Months Ended
Jun. 30, 2020
Jul. 29, 2020
Document and Entity Information [Abstract]    
Entity Registrant Name Lantern Pharma Inc.  
Entity Central Index Key 0001763950  
Amendment Flag false  
Document Type 10-Q  
Document Period End Date Jun. 30, 2020  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2020  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex-transition period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,217,577
Entity File Number 001-39318  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code TX